ARTICLE | Financial News
Mission Therapeutics raises L60M
February 3, 2016 3:08 AM UTC
Mission Therapeutics Ltd. (Cambridge, U.K.) secured L60 million ($85.7 million) in a tranched series C round co-led by existing investor Imperial Innovations Group plc (LSE:IVO) and new investor Woodford Investment Management through its Woodford Patient Capital Trust fund. Existing investors Sofinnova Partners, SR One, Roche Venture Fund and Pfizer Venture Investments also participated. ...